HEM Pharma Inc. (KOSDAQ:376270)
South Korea · Delayed Price · Currency is KRW 31,600
-2,300 (-6.78%)
At close: Oct 8, 2026
HEM Pharma Revenue
HEM Pharma had revenue of 4.57B KRW in the quarter ending June 30, 2026, with 60.82% growth. This brings the company's revenue in the last twelve months to 16.14B, up 1.54% year-over-year. In the year 2025, HEM Pharma had annual revenue of 12.98B, down -13.86%. That makes HEM Pharma the 36,429th largest company in the world by revenue and 2,330th in South Korea.
Revenue (ttm)
16.14B
Revenue Growth
+1.54%
P/S Ratio
14.11
Revenue / Employee
273.59M
Employees
n/a
Market Cap
227.81B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 12.98B | -2.09B | -13.86% |
| Dec 31, 2024 | 15.07B | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.